Kelsey Grammer recently revealed to the New York Post the reason why he had a 30-year falling out with “Cheers” co-star Ted ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Oklahoma lawmakers and schools are pushing for stricter cell phone bans in classrooms, sparking debate among parents, educators, and students on how the policies impact learning and social interaction ...